BIOGEN INC. Cost of Revenue 2007-2026 | BIIB
Beta
What is cost of revenue?
Cost of revenue includes the direct costs attributable to producing goods or delivering services sold by the company.
What is BIOGEN INC.'s current cost of revenue?
BIOGEN INC. (BIIB) annual cost of revenue for 2025 was $2.40B, a 4.06% increase from 2024. BIOGEN INC. cost of revenue for the quarter ending March 31, 2026 was $661.0M.
What was BIOGEN INC.'s cost of revenue in 2024?
BIOGEN INC. annual cost of revenue for 2024 was $2.31B, a 8.80% decline from 2023.
What was BIOGEN INC.'s cost of revenue in 2023?
BIOGEN INC. annual cost of revenue for 2023 was $2.53B, a 11.20% increase from 2022.
What is BIOGEN INC.'s 5-year cost of revenue CAGR?
BIOGEN INC. cost of revenue grew at a compound annual growth rate (CAGR) of 5.90% from FY2020 to FY2025, going from $1.81B to $2.40B over 5 years.
Cost of Revenue History
Year-over-year comparison from 10-K annual reports
Key Statistics
Trend Direction
Stable
CAGR+5.9%
FY2020
$1.81B
→
FY2025
$2.40B
07080910111213141516171819202122232425
5 years selected
Cost of Revenue History
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $2.40B | +4.1% | 10-K |
| FY2024 | $2.31B | -8.8% | 10-K |
| FY2023 | $2.53B | +11.2% | 10-K |
| FY2022 | $2.28B | +8.0% | 10-K |
| FY2021 | $2.11B | +16.9% | 10-K |
| FY2020 | $1.81B | -7.7% | 10-K |
| FY2019 | $1.96B | +7.7% | 10-K |
| FY2018 | $1.82B | +11.4% | 10-K |
| FY2017 | $1.63B | +10.2% | 10-K |
| FY2016 | $1.48B | +19.2% | 10-K |
| FY2015 | $1.24B | +5.9% | 10-K |
| FY2014 | $1.17B | +36.5% | 10-K |
| FY2013 | $857.7M | +57.2% | 10-K |
| FY2012 | $545.5M | +16.9% | 10-K |
| FY2011 | $466.8M | +16.6% | 10-K |
| FY2010 | $400.3M | +4.8% | 10-K |
| FY2009 | $382.1M | -4.9% | 10-K |
| FY2008 | $402.0M | +19.9% | 10-K |
| FY2007 | $335.2M | - | 10-K |
Company: BIOGEN INC.Ticker: BIIBSector: HealthcareIndustry: Biological Products, (No Diagnostic Substances)View company profile →